Clinical Trials Directory

Trials / Completed

CompletedNCT05030116

Clinical Trial for 'Shen Qu Xiao Shi' Oral Liquid in the Treatments of Children's Functional Dyspepsia

Comparison of Shenqu Xiaoshi Oral Liquid and Domperidone Suspension in the Treatment of Functional Dyspepsia in Children: a Randomized, Double-blind, Double-simulated, Multi-center Clinical Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
356 (actual)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
3 Years – 14 Years
Healthy volunteers
Not accepted

Summary

With domperidone suspension as the control, the effect of shenqu xiaoshi oral liquid on functional dyspepsia in children was evaluated objectively through multi-center, randomized, double-blind and double-simulation experiment, which alleviated the clinical symptoms, restored and promoted the normal growth and development of children.

Conditions

Interventions

TypeNameDescription
DRUGShenqu Xiaoshi oral liquidShenqu Xiaoshi oral liquid
DRUGDomperidone suspensionDomperidone suspension

Timeline

Start date
2019-06-26
Primary completion
2020-05-10
Completion
2020-05-23
First posted
2021-09-01
Last updated
2021-09-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05030116. Inclusion in this directory is not an endorsement.

Clinical Trial for 'Shen Qu Xiao Shi' Oral Liquid in the Treatments of Children's Functional Dyspepsia (NCT05030116) · Clinical Trials Directory